We are currently recruiting patients with moderate-to-severe Alopecia Areata for a study that evaluates the Safety and Efficacy of an investigational drug. Would you like to know more about this study?

Study summary:

The study consists of an investigational oral drug that will be administered once daily, for 24 weeks. This investigational drug is experimental, and you will have 2 in 3 chance of receiving investigational drug and a 1 in 3 chance of receiving a placebo (an inactive pill). After the initial 24 weeks are completed, participants may receive the investigational drug for an additional 28 weeks where there will be no placebo.

During the study visits, several assessments and procedures will be conducted to assess your eligibility for the study

This study will last a period of up to 13 months and up to 15 visits

Your participation in this study is at no cost to you.